PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 114 filers reported holding PROVENTION BIO INC in Q3 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $15,454,101 | +134.9% | 641,249 | +3.0% | 0.00% | +200.0% |
Q4 2022 | $6,578,282 | +158.8% | 622,354 | +10.1% | 0.00% | 0.0% |
Q3 2022 | $2,542,000 | +22.9% | 565,062 | +9.3% | 0.00% | – |
Q2 2022 | $2,069,000 | -45.8% | 517,132 | -0.8% | 0.00% | -100.0% |
Q1 2022 | $3,817,000 | +25.8% | 521,547 | -3.4% | 0.00% | – |
Q4 2021 | $3,033,000 | -16.3% | 539,823 | -4.7% | 0.00% | -100.0% |
Q3 2021 | $3,624,000 | -24.9% | 566,205 | -1.1% | 0.00% | 0.0% |
Q2 2021 | $4,826,000 | -23.0% | 572,603 | -4.2% | 0.00% | 0.0% |
Q1 2021 | $6,271,000 | -36.0% | 597,581 | +3.4% | 0.00% | -50.0% |
Q4 2020 | $9,791,000 | +29.3% | 578,026 | -2.1% | 0.00% | 0.0% |
Q3 2020 | $7,575,000 | +155.5% | 590,417 | +181.1% | 0.00% | +100.0% |
Q2 2020 | $2,965,000 | +352.7% | 210,051 | +194.9% | 0.00% | – |
Q1 2020 | $655,000 | -34.5% | 71,228 | +6.1% | 0.00% | – |
Q4 2019 | $1,000,000 | +191.5% | 67,129 | +33.6% | 0.00% | – |
Q3 2019 | $343,000 | -6.8% | 50,259 | +65.1% | 0.00% | – |
Q2 2019 | $368,000 | – | 30,448 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DG Capital Management, LLC | 886,662 | $15,020,000 | 3.18% |
Perceptive Advisors | 4,224,389 | $71,561,000 | 0.77% |
683 Capital Management, LLC | 859,314 | $14,557,000 | 0.69% |
Soleus Capital Management, L.P. | 105,941 | $1,795,000 | 0.24% |
GILDER GAGNON HOWE & CO LLC | 2,359,682 | $39,973,000 | 0.20% |
RICE HALL JAMES & ASSOCIATES, LLC | 247,116 | $4,186,000 | 0.15% |
OCCUDO QUANTITATIVE STRATEGIES LP | 23,127 | $392,000 | 0.12% |
Virtus ETF Advisers LLC | 15,878 | $269,000 | 0.11% |
Newbridge Financial Services Group, Inc. | 6,500 | $110,000 | 0.09% |
Windsor Creek Advisors, LLC | 18,000 | $305,000 | 0.08% |